In a study of the effect of metformin on prostate cancer cells, Ben et al. showed that metformin can reduce intracellular cyclin D1 expression and cell cycle arrest in the G0/G1 stage, thereby inhibiting cell proliferation [27]. This evidence concerns the gene CCND1 and Familial prostate cancer.